Their findings demonstrated notable differences in IL-10 expression between new-onset and treated SLE patients, suggesting that elevated IL-10 levels in recently diagnosed individuals may reflect an active immune response or flare-up [47]. The gene discussed is IL10; the disease is systemic lupus erythematosus.